IC

Ikarian Capital Portfolio holdings

AUM $302M
This Quarter Return
+0.62%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$437M
AUM Growth
+$437M
Cap. Flow
-$126M
Cap. Flow %
-28.81%
Top 10 Hldgs %
31.44%
Holding
211
New
18
Increased
20
Reduced
105
Closed
27

Top Buys

1
BCYC
Bicycle Therapeutics
BCYC
$21.9M
2
APLS icon
Apellis Pharmaceuticals
APLS
$11.5M
3
INBX
Inhibrx, Inc. Common Stock
INBX
$9.39M
4
IMTX icon
Immatics
IMTX
$8.55M
5
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
$6.15M

Top Sells

1
BIIB icon
Biogen
BIIB
$26.5M
2
ALEC icon
Alector
ALEC
$14.1M
3
CRSP icon
CRISPR Therapeutics
CRSP
$10.3M
4
ANVS icon
Annovis Bio
ANVS
$8.86M
5
CGEM icon
Cullinan Oncology
CGEM
$7.61M

Sector Composition

1 Healthcare 97.59%
2 Consumer Staples 0.77%
3 Technology 0.56%
4 Financials 0.17%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CCXI
151
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-471,376
Closed -$6.31M
RETA
152
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
0
– –
MRTX
153
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
0
– –
BCEL
154
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-250,000
Closed -$2.13M
ALPN
155
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
– –
-300,454
Closed -$2.7M
DCPH
156
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
– –
0
– –
PSTX
157
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-85,837
Closed -$861K
TVRD
158
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
– –
-29,335
Closed -$418K
ZLAB icon
159
Zai Lab
ZLAB
$3.48B
– –
0
– –
XBI icon
160
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
WGS icon
161
GeneDx Holdings
WGS
$3.65B
– –
-200,000
Closed -$2.8M
VCEL icon
162
Vericel Corp
VCEL
$1.69B
– –
0
– –
UNH icon
163
UnitedHealth
UNH
$279B
– –
0
– –
TGTX icon
164
TG Therapeutics
TGTX
$5.03B
– –
0
– –
STOK icon
165
Stoke Therapeutics
STOK
$1.08B
– –
0
– –
SPY icon
166
SPDR S&P 500 ETF Trust
SPY
$656B
– –
0
– –
ANAB icon
167
AnaptysBio
ANAB
$630M
– –
-21,553
Closed -$558K
ANVS icon
168
Annovis Bio
ANVS
$44.4M
– –
-103,527
Closed -$8.86M
ASND icon
169
Ascendis Pharma
ASND
$12.1B
– –
-21,825
Closed -$2.87M
ATHA icon
170
Athira Pharma
ATHA
$15.5M
– –
0
– –
AUPH icon
171
Aurinia Pharmaceuticals
AUPH
$1.58B
– –
0
– –
AVIR icon
172
Atea Pharmaceuticals
AVIR
$275M
– –
0
– –
AZN icon
173
AstraZeneca
AZN
$255B
– –
0
– –
BCRX icon
174
BioCryst Pharmaceuticals
BCRX
$1.74B
– –
0
– –
BHC icon
175
Bausch Health
BHC
$2.72B
– –
0
– –
5 6
7
8 9